Medpace Balance Sheet
NASDAQ: MEDPHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medpace financial position
At the end of fiscal 2025, Medpace reported total assets of $1.98 billion, down 6.0% from a year earlier against total liabilities of $1.52 billion. Shareholders' equity stood at $459.1 million, or 23.2% of assets. The company held $497.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 0.74, meaning short-term obligations exceed short-term assets.
Summary generated from market data by MetaCap's automated system. Methodology
Medpace balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 497.05M | 669.44M | 245.45M | 28.27M | 461.30M | 277.77M | 131.92M | 23.27M | 26.48M | 37.10M |
| Receivables | 402.08M | 296.44M | 298.40M | 253.40M | 186.43M | 160.96M | 155.66M | 133.45M | 83.08M | 79.77M |
| Total Current Assets | 989.62M | 1.03B | 593.83M | 333.96M | 690.91M | 473.65M | 317.03M | 178.11M | 129.97M | 133.25M |
| Property, Plant & Equipment | 131.06M | 123.61M | 120.59M | 109.85M | 93.15M | 85.02M | 47.29M | 52.26M | 48.74M | 43.80M |
| Goodwill | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 662.40M | 660.98M | 660.98M | 660.98M |
| Intangible Assets | 33.42M | 34.37M | 35.81M | 38.01M | 41.36M | 46.47M | 54.35M | 69.18M | 98.74M | 136.07M |
| Total Assets | 1.98B | 2.10B | 1.66B | 1.35B | 1.66B | 1.39B | 1.14B | 967.93M | 950.72M | 979.11M |
| Accounts Payable | 28.14M | 32.53M | 31.87M | 33.07M | 25.68M | 26.55M | 22.40M | 16.74M | 16.67M | 10.91M |
| Short-Term Debt | — | — | 0 | 50.00M | 0 | — | — | 0 | 16.50M | 12.38M |
| Total Current Liabilities | 1.34B | 1.10B | 925.13M | 803.47M | 557.22M | 440.11M | 343.00M | 257.03M | 192.71M | 168.60M |
| Long-Term Debt | — | — | — | — | — | — | 0 | 79.72M | 205.11M | 151.27M |
| Total Liabilities | 1.52B | 1.28B | 1.10B | 966.11M | 707.01M | 584.90M | 416.79M | 378.23M | 447.19M | 368.39M |
| Shareholders' Equity | 459.07M | 825.54M | 558.95M | 386.39M | 952.93M | 805.78M | 726.28M | 598.86M | 509.26M | 610.71M |
| Retained Earnings | -459.98M | 8.17M | -221.65M | -359.83M | 234.98M | 115.23M | 68.11M | -41.49M | -120.40M | -9.58M |
| Total Debt | — | — | 0 | 50.00M | 0 | — | 0 | 79.72M | 221.61M | 163.64M |
| Net Cash (Debt) | 497.05M | 669.44M | 245.45M | -21.73M | 461.30M | 277.77M | 131.92M | -56.45M | -195.13M | -126.54M |
| Shares Outstanding | 28.37M | 30.63M | 30.75M | 31.09M | 36.01M | 35.52M | 36.07M | 35.67M | 35.47M | 40.66M |
This table shows 10 annual periods of Medpace's balance sheet, from FY 2025 back to FY 2016, across 17 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow MEDP's reporting calendar. What is a balance sheet?